Eledon Pharmaceuticals
ELDN
ELDN
20 hedge funds and large institutions have $18.2M invested in Eledon Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $27.2M → $18.2M (-$9.05M)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$268K | |
| 2 | +$261K | |
| 3 | +$164K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$136K |
| 5 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
+$82K |
Top Sellers
| 1 | -$902K | |
| 2 | -$207K | |
| 3 | -$129K | |
| 4 |
D.E. Shaw & Co
New York
|
-$6.77K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$2.26K |